Patents
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
03/2010
03/03/2010EP2159230A1 Anti-TNF antibodies, compositions, methods and uses
03/03/2010EP1162998B1 Vaccine against streptococcus pneumoniae capsular polysaccharides
03/03/2010CN101658673A Method of treating diabetes
03/02/2010US7671092 Paclitaxel enhancer compounds
02/2010
02/24/2010CN101654470A Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof
02/24/2010CN101654437A Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds
02/24/2010CN100591657C Indane acetic acid compound
02/16/2010CA2385938C Cyclic amine compounds as ccr5 antagonists
02/11/2010US20100035891 Pharmaceutically Active Compounds
02/11/2010US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof
01/2010
01/27/2010CN101633655A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
01/27/2010CN101633636A Peptidomimetic protease inhibitors
01/20/2010EP1599227B1 Methods of immunomodulation in animals
01/19/2010CA2373255C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
01/12/2010US7645761 Indoline derivatives
01/12/2010US7645734 Compositions and methods for treating and preventing heart tissue degeneration and uses thereof
01/12/2010CA2481461C Derivatives of n-[phenyl(piperidin-2-yl) methyl] benzamide, the preparation method thereof and application of same in therapeutics
01/12/2010CA2407838C Pyrano, piperidino, and thiopyrano compounds and methods of use
01/06/2010EP2140878A1 Vaccine against streptococcus pneumoniae
12/2009
12/31/2009US20090326221 New oxabispidine compunds useful in the treatment of cardiac arrhythmias
12/31/2009US20090326038 Method for treating a immunology-related disease
12/31/2009US20090324542 optic neuritis; fingolimod or 2-amino-2-{2-[4-(1-oxo-5-phenylpentyl)phenyl]ethyl}propane-1,3-diol or salts as SP1 agonist
12/30/2009CN101612401A Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
12/29/2009US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof
12/23/2009CN100572364C HIV replication inhibiting pyrimidines and triazines
12/17/2009US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/16/2009CN100569286C Attenuated strains of vibrio cholerae with freeze-dry type and modified biological security for orally inoculability
12/08/2009US7629335 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour
12/03/2009US20090298841 serotonin receptor modulators such as 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline, used for treating obesity, nervous system disorders such as dementia, schizophrenia and Alzheimer's disease, and as cognition activators
12/02/2009CN100564358C Method for making 4-(3,4-dichlorophenoxy)piperidine
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
11/2009
11/25/2009CN100562338C Beta-amyloid-analogue-cell epitop vaccine
11/18/2009EP1218354B1 Quinazoline derivatives and their use as pharmaceuticals
11/18/2009CN101579344A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/18/2009CN101579343A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/17/2009CA2432181C Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
11/17/2009CA2398992C Therapeutic or preventive agent for pulmonary insufficiency containing a diaminotrifluoromethylpyridine derivative
11/12/2009US20090281123 Novel thiazolo (4,5-d) pyrimidine compounds novel compounds
11/11/2009EP1406870B1 Taxol enhancer compounds
11/11/2009CN101574348A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
11/11/2009CN101574347A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
11/10/2009CA2401637C N-(heterocyclyl)benzene- or - pyridinesulphonamides as antithrombotic and anticoagulant agents
11/05/2009US20090275751 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
11/04/2009EP1311488B1 Substituted imidazoles as tafia inhibitors
10/2009
10/29/2009US20090270446 Diamine derivatives
10/27/2009CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/22/2009US20090263427 Vaccines for mycoplasma bovis and methods of use
10/21/2009CN100551370C Use of Ranolazine in preparing pharmaceutical composition for treating diabetes
10/20/2009CA2407371C Quinazoline derivatives for the treatment of tumours
10/13/2009US7601837 Quinoline derivatives and their use as 5-HT6 ligands
10/13/2009CA2368274C C10 ester substituted taxanes as antitumor agents
10/07/2009EP2106797A2 Controlled release oxycodone compositions
10/07/2009EP2106796A2 Controlled release oxycodone compositions
10/07/2009CN101550190A An anti-il-12 antibody, a composition, a method and the function
09/2009
09/30/2009CN101543507A Immunostimulatory nucleic acids
09/30/2009CN100545160C Diamine derivatives
09/29/2009CA2521391C Potassium salt of s-omeprazole as intermediate in the preparation of the magnesium salt of s-omeprazole trihydrate
09/29/2009CA2349330C Nitrogen containing heterobicycles as factor xa inhibitors
09/24/2009US20090238821 Humanized antibodies that sequester amyloid beta peptide
09/23/2009CN100542606C Vaccine composition comprising tumour antigen and adjuvant composition
09/22/2009US7592350 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
09/22/2009US7592171 Vibrio cholerae with improved biological safety features in freeze dried form
09/16/2009EP2100605A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer
09/16/2009EP1564210B1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
09/16/2009EP1192125B9 Mono-substituted 3-propyl gamma-aminobutyric acids
09/16/2009CN101531631A Substituted pyridinones as modulators of p38 map kinase
09/10/2009US20090227504 Pegylated Factor VII Glycoforms
09/09/2009CN101524540A Selective dopamine D4 receptor agonists used for treating sexual disorder
09/08/2009US7585870 improved ability to inhibit the replication of mutant strains of drug or multidrug resistant HIV strains; Indene/benzofuran Substituted Pyrimidines
09/03/2009US20090221546 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
09/03/2009US20090220550 Vaccines for Mycoplasma bovis and methods of use
09/01/2009US7582733 Modified immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy
08/2009
08/27/2009US20090215795 Cyclic amidine derivatives
08/26/2009EP1462442B1 Crystals of bicalutamide and process for their production
08/12/2009CN101502648A 疫苗 Vaccine
08/05/2009EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade
08/05/2009EP1399445B1 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
08/05/2009EP1249233B9 Npyy5 antagonists
08/05/2009CN100522991C Peptidomimetic protease inhibitors
07/2009
07/30/2009US20090191188 Immunostimulatory nucleic acids
07/28/2009US7566710 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine
07/23/2009US20090186908 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
07/22/2009EP1391456B1 2-iminoimidazole derivatives
07/22/2009CN100516034C Inhibitors of aspartyl protease
07/21/2009US7563811 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents
07/16/2009US20090182143 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
07/14/2009US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy
07/09/2009US20090175965 Antiscarring, antiaging, photodamaged skin or as a depilatory; unsaponifiable component from canola oil, rapeseed oil, sunflower oil, palm oil, maize oil, sesame oil, wheatgerm oil and one from avocado oil, lupin oil, or soybean oil
07/08/2009CN100509811C Azaindoles
07/01/2009EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
06/2009
06/25/2009US20090162433 Method of treatment
06/23/2009CA2459400C Plaster for the treatment of dysfunctions and disorders of nails
06/23/2009CA2449874C New indole derivatives with 5-ht6 receptor affinity
06/18/2009US20090156567 Novel anti-inflammatory androstane derivative
06/17/2009EP1390378B1 Pharmaceutically active uridine esters
06/16/2009CA2381097C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
06/11/2009US20090148444 Pharmaceutical composition for treating immune diseases
06/10/2009CN100497386C Antibodies of non-functional P2X7 receptor and its uses
06/10/2009CN100497340C Condensed purine derivatives as A1 adenosine receptor antagonists
06/10/2009CN100496607C Combination of a NSAID and a PDE-4 inhibitor
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 32